Reported about 9 hours ago
Hims & Hers Health Inc. experienced an 8% increase in shares after announcing talks with Novo Nordisk A/S regarding the potential sale of its new obesity pill. Although no agreement has been finalized, analysts suggest that a partnership could enhance Hims' revenue prospects. The company also reported higher-than-expected quarterly revenue but adjusted its sales forecast downward.
Source: YAHOO